Shots: The P-Ib study involves assessing of Ipatasertib + Tecentriq + CT (paclitaxel/nab-paclitaxel) in 26 patients with locally advanced or metastatic TNBC P-Ib study results: ORR 73%; median duration of […]readmore
Tags : Ipatasertib